TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations.
Mol Cancer Ther. 2018 Aug;17(8):1648-1658. doi: 10.1158/1535-7163.MCT-17-1206. Epub 2018 May 10.
Mol Cancer Ther. 2018.
PMID: 29748209